The DOI matches its Crossref record; 122 of the 122 references it cites were found in a registry or an index.
Lectin-mediated mucosal delivery of drugs and microparticles
Open accessAbstract
Absorption of drugs and vaccines at mucosal surfaces may be enhanced by conjugation to appropriate bioadhesins which bind to mucosal epithelia. Bioadhesins might also permit cell- and site-selective targeting. One approach is to exploit surface carbohydrates on mucosal epithelial cells for lectin-mediated delivery. We review work supporting the use of lectins as mucosal bioadhesins in the gastrointestinal and respiratory tracts, the oral cavity and the eye. The gastrointestinal tract is particularly favoured for mucosal delivery. Many studies have demonstrated that the antigen sampling intestinal M cells offer a portal for absorption of colloidal delivery vehicles. Evidence is presented that M cell targeting may be achieved using M cell-specific lectins, microbial adhesins or immunoglobulins. While many hurdles must be overcome before mucosal bioadhesins can guarantee consistent, safe, effective mucosal delivery, this is an exciting area of research that has important implications for future drug and vaccine formulation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“lectins are often toxic and susceptible to proteolytic degradation in the GI tract, which renders some of them inappropriate for in vivo application [105,117].”
From Use of lectin-functionalized particles for oral immunotherapy (2012) · cites this paper as [105]
Citations
Cites
Gastrointestinal Uptake of Biodegradable Microparticles: Effect of Particle Size
Desai, M. P., Labhasetwar, V. D., Amidon, G. L., & Levy, R. J. (1996) · Pharmaceutical Research · doi:10.1023/a:1016085108889 · Cited by 942
Nanoparticle Uptake by the Rat Gastrointestinal Mucosa: Quantitation and Particle Size Dependency
Jani, P., Halbert, G. W., Langridge, J., & Florence, A. T. (1990) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1990.tb07033.x · Cited by 920
Jones, B. D., Ghori, N., & Falkow, S. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.180.1.15 · Cited by 883
Isberg, R. R., & Leong, J. M. (1990) · Cell · doi:10.1016/0092-8674(90)90099-z · Cited by 798
Eldridge, J. H., Hammond, C., Meulbroek, J. A., Staas, J. K., Gilley, R. M., & Tice, T. R. (1990) · Journal of Controlled Release · doi:10.1016/0168-3659(90)90133-e · Cited by 689
Conversion by Peyer's Patch Lymphocytes of Human Enterocytes into M Cells that Transport Bacteria
Kernéis, S. M., Bogdanova, A. A., Kraehenbühl, J.-P., & Pringault, E. (1997) · Science · doi:10.1126/science.277.5328.949 · Cited by 630
Isberg, R. R., Voorhis, D. L., & Falkow, S. (1987) · Cell · doi:10.1016/0092-8674(87)90335-7 · Cited by 597
The Oral Absorption of Micro- and Nanoparticulates: Neither Exceptional Nor Unusual
Florence, A. T. (1997) · Pharmaceutical Research · doi:10.1023/a:1012029517394 · Cited by 498
Intestinal M Cells: A Pathway for Entry of Reovirus into the Host
Wolf, J. L., Rubin, D. H., Finberg, R. W., Kauffman, R. S., Sharpe, A. H., Trier, J. S., & Fields, B. N. (1981) · Science · doi:10.1126/science.6259737 · Cited by 483
Immune responses to dietary antigens: oral tolerance
Ströbel, S., & Mowat, A. M. (1998) · Immunology Today · doi:10.1016/s0167-5699(97)01239-5 · Cited by 454
Research works printed but not linked: 3
- Caston, 1990, The potential of fimbrial proteins for delaying intestinal transit of oral drug delivery systems, Proc. Control. Release Soc., 17, 313
- Wilson, 1998, Identification of cell subpopulations in human tonsillar epithelium [abstract], J. Anat., 192, D13
- Russell-Jones, 1988, Vitamin B12: A novel carrier for orally presented antigens, Proc. Int. Symp. Control. Release Bioact. Mater., 15, 85
Cited by
Sorted by citations
Oral drug delivery with polymeric nanoparticles: The gastrointestinal mucus barriers
Ensign, L. M., Cone, R. A., & Hanes, J. S. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.12.009 · Cited by 1,671
Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach
des Rieux, A., Fievez, V., Garinot, M., Schneider, Y.-J., & Préat, V. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.08.013 · Cited by 1,305
Nicolas, J., Mura, S., Brambilla, D., Mackiewicz, N., & Couvreur, P. (2013) · Chem. Soc. Rev. · doi:10.1039/c2cs35265f · Cited by 1,270
Bioavailability of nanoparticles in nutrient and nutraceutical delivery
Acosta, E. (2008) · Current Opinion in Colloid & Interface Science · doi:10.1016/j.cocis.2008.01.002 · Cited by 896
Mucoadhesive polymeric platforms for controlled drug delivery
Andrews, G. P., Laverty, T. P., & Jones, D. S. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.09.028 · Cited by 877
From Sewer to Saviour—Targeting the Lymphatic System to Promote Drug Exposure and Activity
Trevaskis, N. L., Kaminskas, L. M., & Porter, C. J. H. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4608 · Cited by 654
Advances in oral transmucosal drug delivery
Patel, V. F., Liu, F., & Brown, M. B. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.01.027 · Cited by 579
Hua, S. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00524 · Cited by 527
PEGylation for enhancing nanoparticle diffusion in mucus
Huckaby, J. T., & Lai, S. K. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.08.010 · Cited by 484
Yun, Y., Cho, Y. W., & Park, K. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.10.007 · Cited by 443
Rieux, A. D., Fiévez, V., Théate, I., Mast, J., Véronique Préat, A., & Schneider, Y. (2007) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2006.12.006 · Cited by 322
Rieux, A. D., Ragnarsson, E., Gullberg, E., Véronique Préat, A., Schneider, Y., & Artursson, P. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.04.015 · Cited by 298
Drug delivery strategies in the therapy of inflammatory bowel disease
Lautenschläger, C., Schmidt, C., Fischer, D., & Stallmach, A. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.10.001 · Cited by 287
Lectin-modified solid lipid nanoparticles as carriers for oral administration of insulin
Zhang, N., Ping, Q. N., Huang, G., Xu, W., Cheng, Y., & Han, X. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.07.026 · Cited by 286
Infection microenvironment-related antibacterial nanotherapeutic strategies
Wang, Z., Liu, X., Duan, Y., & Huang, Y. P. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.121249 · Cited by 271
Polymeric nanoparticle drug delivery technologies for oral delivery applications
Pridgen, E. M., Alexis, F., & Farokhzad, O. C. (2015) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2015.1018175 · Cited by 279
Sharma, A., Sharma, S., & Khuller, G. K. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh411 · Cited by 251
The lectin–cell interaction and its implications to intestinal lectin-mediated drug delivery
Gabor, F., Bogner, E., Weissenboeck, A., & Wirth, M. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.015 · Cited by 247
Exploiting M cells for drug and vaccine delivery
Clark, M. A. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00149-1 · Cited by 247
Self-citationThe challenges of oral drug delivery via nanocarriers
Reinholz, J., Landfester, K., & Mailänder, V. (2018) · Drug Delivery · doi:10.1080/10717544.2018.1501119 · Cited by 237
Xu, Y., Shrestha, N., Véronique Préat, A., & Beloqui, A. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.04.006 · Cited by 219
Transport of Nanoparticles Across the Rat Nasal Mucosa
Brooking, J., Davis, S. S., & Illum, L. (2001) · Journal of drug targeting · doi:10.3109/10611860108997935 · Cited by 206
Surface Modification of Lipid-Based Nanoparticles
Xu, Y., Fourniols, T., Labrak, Y., Véronique Préat, A., Beloqui, A., & Rieux, A. D. (2022) · ACS Nano · doi:10.1021/acsnano.2c02347 · Cited by 196
A focus on mucoadhesive polymers and their application in buccal dosage forms
Russo, E., Selmin, F., Baldassari, S., Gennari, C. G. M., Caviglioli, G., Cilurzo, F., Minghetti, P., & Parodi, B. (2015) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2015.06.016 · Cited by 182
Hao, J., & Heng, P. W. S. (2003) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-120024178 · Cited by 186
Nanotechnology-Based Approach in Tuberculosis Treatment
Nasiruddin, M., Neyaz, M. K., & Das, S. (2017) · Tuberculosis Research and Treatment · doi:10.1155/2017/4920209 · Cited by 177
Investigation of lectin-modified insulin liposomes as carriers for oral administration
Zhang, N., Ping, Q. N., Huang, G., & Xu, W. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.01.018 · Cited by 162
The role of M cells in infection
Jepson, M. A., & Clark, M. A. (2001) · Microbes and Infection · doi:10.1016/s1286-4579(01)01478-2 · Cited by 162
Self-citationParticle uptake by Peyer’s patches: a pathway for drug and vaccine delivery
Shakweh, M., Ponchel, G., & Fattal, E. (2004) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.1.1.141 · Cited by 161
Oral transmucosal drug delivery for pediatric use
Lam, J. K. W., Xu, Y., Worsley, A., & Wong, I. C. K. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.08.011 · Cited by 152
Reddy, P. C., Chaitanya, K., & Rao, Y. M. (2011) · Europe PMC (PubMed Central) · Cited by 151
Designing the new generation of intelligent biocompatible carriers for protein and peptide delivery
Wagner, A. M., Gran, M. P., & Peppas, N. A. (2018) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2018.01.013 · Cited by 155
Wang, D., Jiang, Q., Dong, Z., Meng, T., Hu, F., Wang, J., & Yuan, H. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115130 · Cited by 144
M cell targeting by lectins: a strategy for mucosal vaccination and drug delivery
Jepson, M. A., Clark, M. A., & Hirst, B. H. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.018 · Cited by 130
Self-citationTargeting polymerised liposome vaccine carriers to intestinal M cells
Clark, M. A., Blair, H. J., Liang, L., Brey, R. N., Brayden, D. J., & Hirst, B. H. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00258-4 · Cited by 130
Self-citationIn vitro and in vivo study of N-trimethyl chitosan nanoparticles for oral protein delivery
Chen, F., Zhang, Z., Yuan, F., Qin, X., Wang, M., & Huang, Y. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.07.035 · Cited by 131
Yoshikawa, T., Inoüe, R., Matsumoto, M., Yajima, T., Ushida, K., & Iwanaga, T. (2011) · Histochemistry and Cell Biology · doi:10.1007/s00418-011-0779-1 · Cited by 132
Mo, Y., & Lim, L. Y. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.06.024 · Cited by 128
Plant protein-based hydrophobic fine and ultrafine carrier particles in drug delivery systems
Malekzad, H., Mirshekari, H., Zangabad, P. S., Basri, S. M. M., Baniasadi, F., Aghdam, M. S., Karimi, M., & Hamblin, M. R. (2017) · Critical Reviews in Biotechnology · doi:10.1080/07388551.2017.1312267 · Cited by 115
Wong, C. Y. J., Al‐Salami, H., & Dass, C. R. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.07.041 · Cited by 116
Hunter, A. C., Elsom, J., Wibroe, P. P., & Moghimi, S. M. (2012) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2012.07.005 · Cited by 108
Peppas, N. A., & Kavimandan, N. J. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2006.04.014 · Cited by 109
Yin, Y.-S., Chen, D., Qiao, M., Wei, X., & Hu, H. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.06.024 · Cited by 107
Drug delivery systems based on sugar-macromolecule conjugates.
Davis, B. G., & Robinson, M. A. (2002) · PubMed · Cited by 107
Drug Delivery from the Oral Cavity: A Focus on Mucoadhesive Buccal Drug Delivery Systems
Shinkar, D. M., Dhake, A. S., & Setty, C. D. S. (2012) · PDA Journal of Pharmaceutical Science and Technology · doi:10.5731/pdajpst.2012.00877 · Cited by 106
Nanomedicine for increasing the oral bioavailability of cancer treatments
Parodi, A., Buzaeva, P., Nigovora, D., Baldin, A. V., Kostyushev, D. S., Chulanov, V., Savvateeva, L. V., & Zamyatnin, A. A. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-01100-2 · Cited by 104
Navigating albumin-based nanoparticles through various drug delivery routes
Tan, Y. L., & Ho, H. K. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.01.051 · Cited by 99
Peyer's Patches and M Cells as Potential Sites of the Inflammatory Onset in Crohn's Disease
Gullberg, E., & Söderholm, J. D. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1326.028 · Cited by 94
Crossing the barrier: Targeting epithelial receptors for enhanced oral vaccine delivery
Devriendt, B., Geest, B. G. D., Goddeeris, B. M., & Cox, E. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.02.006 · Cited by 94
Mechanistic study of the uptake of wheat germ agglutinin-conjugated PLGA nanoparticles by A549 cells
Mo, Y., & Lim, L. Y. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10507 · Cited by 91
Nano and microscale delivery platforms for enhanced oral peptide/protein bioavailability
Tong, T., Wang, L., You, X., & Wu, J. (2020) · Biomaterials Science · doi:10.1039/d0bm01151g · Cited by 89
Lectin-functionalized carboxymethylated kappa-carrageenan microparticles for oral insulin delivery
Leong, K. H., Chung, L. Y., Noordin, M. I., Onuki, Y., Morishita, M., & Takayama, K. (2011) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2011.04.070 · Cited by 85
Martirosyan, A. S., Bazes, A., & Schneider, Y. (2013) · Nanotoxicology · doi:10.3109/17435390.2013.812258 · Cited by 86
Engineering strategies to enhance nanoparticle-mediated oral delivery
Yamanaka, Y. J., & Leong, K. W. (2008) · Journal of Biomaterials Science Polymer Edition · doi:10.1163/156856208786440479 · Cited by 81
Polysaccharides-based nanocarriers enhance the anti-inflammatory effect of curcumin
Luo, W. H., Bai, L., Zhang, J., Li, Z., Liu, Y., Tang, X., Xia, P., Xu, M., Shi, A., Liu, X., et al. (2023) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2023.120718 · Cited by 79
Shreya, A. B., Raut, S. Y., Managuli, R. S., Udupa, N., & Mutalik, S. (2018) · AAPS PharmSciTech · doi:10.1208/s12249-018-1262-2 · Cited by 79
Investigation of lectinized liposomes as M-cell targeted carrier-adjuvant for mucosal immunization
Gupta, P. N., & Vyas, S. P. (2010) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2010.08.027 · Cited by 78
Implication of nanoparticles/microparticles in mucosal vaccine delivery
Vyas, S. P., & Gupta, P. N. (2007) · Expert Review of Vaccines · doi:10.1586/14760584.6.3.401 · Cited by 76
Micromachined devices: The impact of controlled geometry from cell-targeting to bioavailability
Tao, S. L., & Desai, T. A. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.09.019 · Cited by 73
Antigen Delivery to Mucosa-Associated Lymphoid Tissues Using Liposomes as a Carrier
Zhou, F., & Neutra, M. R. (2002) · Bioscience Reports · doi:10.1023/a:1020103109483 · Cited by 73
Oral vaccination in man using antigens in particles: current status
Brayden, D. J. (2001) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(01)00175-0 · Cited by 72
Mucoadhesive Polymers for Oral Transmucosal Drug Delivery: A Review
Sebastián, J. V. B., Paderni, C., Termine, N., Campisi, G., Russo, L. L., Compilato, D., & Fede, O. D. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212803307545 · Cited by 71
Nanomedicine and experimental tuberculosis: facts, flaws, and future
Pandey, R., & Ahmad, Z. (2011) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2011.01.009 · Cited by 66
BALLDock/SLICK: A New Method for Protein-Carbohydrate Docking
Kerzmann, A., Fuhrmann, J., Kohlbacher, O., & Neumann, D. (2008) · Journal of Chemical Information and Modeling · doi:10.1021/ci800103u · Cited by 65
Novel strategies for the buccal delivery of macromolecules
Morales, J. O., & McConville, J. T. (2014) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2014.892960 · Cited by 65
Intestinal M cells and their role in bacterial infection
Clark, M. A., & Jepson, M. A. (2003) · International Journal of Medical Microbiology · doi:10.1078/1438-4221-00242 · Cited by 65
Self-citationMicrofabrication of Multilayer, Asymmetric, Polymeric Devices for Drug Delivery
Tao, S. L., & Desai, T. A. (2005) · Advanced Materials · doi:10.1002/adma.200500017 · Cited by 65
Microparticle vaccine approaches to stimulate mucosal immunisation
Brayden, D. J., & Baird, A. W. (2001) · Microbes and Infection · doi:10.1016/s1286-4579(01)01445-9 · Cited by 64
M cell targeting engineered biomaterials for effective vaccination
Islam, M. A., Firdous, J., Badruddoza, A. Z. M., Reesor, E., Azad, M. A., Hasan, A., Lim, M., Cao, W., Guillemette, S. R., & Cho, C. S. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.10.041 · Cited by 64
Guo, Y., & Singh, A. P. (2019) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2019.05.014 · Cited by 63
Exploiting receptor biology for oral vaccination with biodegradable particulates
Foster, N. M., & Hirst, B. H. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.09.009 · Cited by 60
Self-citationM cell targeting with Aleuria aurantia lectin as a novel approach for oral allergen immunotherapy
Roth-Walter, F., Schöll, I., Untersmayr, E., Fuchs, R., Boltz-Nitulescu, G., Weissenböck, A., Scheiner, O., Gabor, F., & Jensen-Jarolim, E. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.08.010 · Cited by 58
Carbohydrate-protein interactions: advances and challenges
Zhang, S., Chen, K. Y., & Zou, X. (2021) · Communications in Information and Systems · doi:10.4310/cis.2021.v21.n1.a7 · Cited by 57
Concanavalin A conjugated biodegradable nanoparticles for oral insulin delivery
Hurkat, P., Jain, A., Jain, A., Shilpi, S., Gulbake, A., & Jain, S. (2012) · Journal of Nanoparticle Research · doi:10.1007/s11051-012-1219-4 · Cited by 57
Oral insulin delivery: Barriers, strategies, and formulation approaches: A comprehensive review
Shetty, S., Halagali, P., Johnson, A. P., Spandana, K. M. A., & Gangadharappa, H. V. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.125114 · Cited by 62
Ainslie, K. M., Kraning, C. M., & Desai, T. A. (2008) · Lab on a Chip · doi:10.1039/b800604k · Cited by 56
Mucosal targeting of allergen-loaded microspheres by Aleuria aurantia lectin
Roth-Walter, F., Schöll, I., Untersmayr, E., Ellinger, A., Boltz-Nitulescu, G., Scheiner, O., Gabor, F., & Jensen-Jarolim, E. (2005) · Vaccine · doi:10.1016/j.vaccine.2004.11.052 · Cited by 55
Breaking the barricade of oral chemotherapy through polysaccharide nanocarrier
Dey, M., Das, M., Chowhan, A., & Giri, T. K. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.02.094 · Cited by 56
Development of therapeutic proteins: advances and challenges
Akash, M. S. H., Rehman, K., TARIQ, M., & Chen, S. (2015) · TURKISH JOURNAL OF BIOLOGY · doi:10.3906/biy-1411-8 · Cited by 55
Biomimetic and bioinspired strategies for oral drug delivery
Hu, X., Yang, G., Chen, S., Luo, S., & Zhang, J. (2019) · Biomaterials Science · doi:10.1039/c9bm01378d · Cited by 54
Wang, Y.-C., Kao, S., & Hsieh, H. (2003) · Biomacromolecules · doi:10.1021/bm0256294 · Cited by 52
Song, J. G., Lee, S. H., & Han, H. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-020-00750-y · Cited by 50
Sonawane, N. D., Zhao, D., Zegarra‐Moran, O., Galietta, L. J. V., & Verkman, A. S. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.02.018 · Cited by 50
Pooja, D., Tunki, L., Kulhari, H., Reddy, B. B., & Sistla, R. (2015) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2015.09.008 · Cited by 48
Walter, F., Schöll, I., Untersmayr, E., Ellinger, A., Boltz-Nitulescu, G., Scheiner, O., Gabor, F., & Jensen-Jarolim, E. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.01.057 · Cited by 47
SLICK − Scoring and Energy Functions for Protein−Carbohydrate Interactions
Kerzmann, A., Neumann, D., & Kohlbacher, O. (2006) · Journal of Chemical Information and Modeling · doi:10.1021/ci050422y · Cited by 47
Re-evaluating the importance of carbohydrates as regenerative biomaterials
Oldenkamp, H. F., Ramirez, J. E. V., & Peppas, N. A. (2018) · Regenerative Biomaterials · doi:10.1093/rb/rby023 · Cited by 46
Hunter, A. C., Elsom, J., Wibroe, P. P., & Moghimi, S. M. (2012) · Maturitas · doi:10.1016/j.maturitas.2012.05.014 · Cited by 48
Sakuma, S., Yano, T., Masaoka, Y., Kataoka, M., Hiwatari, K., Tachikawa, H., Shoji, Y., Kimura, R., Ma, H., Yang, Z., et al. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.10.017 · Cited by 45
Targeting approaches to oral drug delivery
Lambkin, I., & Pinilla, C. (2002) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2.1.67 · Cited by 44
Strategies for Enhanced Peptide and Protein Delivery
McCrudden, M., Singh, T. R. R., Migalska, K., & Donnelly, R. F. (2013) · Therapeutic Delivery · doi:10.4155/tde.13.31 · Cited by 44
Roth-Walter, F., Bohle, B., Schöll, I., Untersmayr, E., Scheiner, O., Boltz-Nitulescu, G., Gabor, F., Brayden, D. J., & Jensen-Jarolim, E. (2005) · Immunology Letters · doi:10.1016/j.imlet.2005.03.020 · Cited by 42
Novel Mucoadhesive Polymers for Nasal Drug Delivery
Anand, U., Feridooni, T., & Agu, R. U. (2012) · InTech eBooks · doi:10.5772/52560 · Cited by 41
Use of lectin-functionalized particles for oral immunotherapy
Diesner, S. C., Wang, X.-Y., Jensen-Jarolim, E., Untersmayr, E., & Gabor, F. (2012) · Therapeutic Delivery · doi:10.4155/tde.11.146 · Cited by 40
The Potential of Films as Transmucosal Drug Delivery Systems
de Carvalho, A. C. W., Paiva, N. F., Demonari, I. K., Ferreira, M. P., do Couto, R. O., de Freitas, O., & Vicentini, F. T. M. C. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15112583 · Cited by 39
Brooks, A. E. (2015) · Frontiers in Chemistry · doi:10.3389/fchem.2015.00065 · Cited by 39
Oromucosal delivery of macromolecules: Challenges and recent developments to improve bioavailability
Rawas‐Qalaji, M., Thu, H. E., & Hussain, Z. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.10.059 · Cited by 37
Mishra, S. K., Adam, J., Wimmerová, M., & Koča, J. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci200529n · Cited by 37
Diagnostic and Therapeutic Uses of Nanomaterials in the Brain
Garbayo, E., de Mendoza, A. E., & Blanco‐Prieto, M. J. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666140815124246 · Cited by 38
Liu, H., Meagher, C. K., Moore, C. P., & Phillips, T. E. (2005) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.05-0280 · Cited by 36
Metadata
- Authors
- Clark, M. A., Hirst, B. H., & Jepson, M. A.
- Affiliations
- Newcastle University (GB)
- University of Bristol (GB)
- Corresponding author
- Jepson, Mark A
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2000-09
- Volume
- 43
- Issue
- 2-3
- Pages
- 207-223
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2063013932
- Cited by
- 236
- References
- 121
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 8 · 2023: 11 · 2022: 6 · 2021: 12 · 2020: 13 · 2019: 14 · 2018: 8 · 2017: 10 · 2016: 7 · 2015: 14 · 2014: 6 · 2013: 14 · 2012: 17
- FWCI
- 1.41
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Locations
- Advanced Drug Delivery Reviews (publishedVersion)
- PubMed (publishedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
- Keywords
- lectins, mucosal drug delivery, M cells, intestinal mucosa, respiratory mucosa, oral mucosa, ocular drug delivery, microparticles, colloidal drug delivery, vaccine delivery, gastrointestinal tract
- MeSH terms
- Animals, Gastric Mucosa, Humans, Intestinal Absorption, Intestinal Mucosa, Nasal Mucosa, Vaccines, Drug Delivery Systems, Lectins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review